On 14 September 2018, Press Conference - Jiuzhitang Qihang Fund’s Investment in Stemdica Cell Technologies, Inc. & Global Stem Cell Industry Development Summit was held in Beijing.

2019-02-25 17:19:00

Jiuzhitang Maker was officially awarded Certificate of Zhongguancun High Technology Enterprise.

Approved by the Administration Committee of Zhongguancun Science & Technology Park, Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. ...

2019-01-23 02:15:00

Jiuzhitang Maker signed the Cooperation Agreement on Jointly Building Jiuzhitang-ALTACO International Medical center for Stem Cells with Kazakhstan-based LLP "ALTACO-XXI" in the China-Kazakhstan Horgos Frontier International Cooperation Center.

Jiuzhitang Maker signed the Cooperation Agreement on Jointly Building Jiuzhitang-ALTACO International Medical center for Stem Cells with ...

2019-01-12 14:45:00

New Progress Achieved in Jiuzhitang M&A Fund’s Investment in Stem Cell Business

On January 12, 2019, Jiuzhitang Co., Ltd. made an announcement on latest progress its M&A fund achieved in investment efforts. ...

2018-11-05 15:55:00

Jiuzhitang Maker selected as one of the Ten Key companies received “Comprehensive Service Package” offered by Daxing District

Daxing District Development and Reform Commission and Daxing Biomedicine Industry Base delivered “Comprehensive Service Package”...

2018-09-12 15:34:00

Stem cell drugs formulated with Stemedica’s products approved in Kazakhstan for treatment of acute myocardial infarction

On 12 September 2018, Stemedica completed its Phase III clinical trial of using mesenchymal stem cells to treat acute myocardial infarction ...

Last Page